Table 3.
Univariate and multivariate analysis of risk factors of tumor recurrence in 122 patients.
Univariate | Multivariate | |||
---|---|---|---|---|
HR (95%CI) | P | HR (95%CI) | p | |
Age ≥55 | 0.88 (0.57–1.36) | 0.576 | ||
male | 0.57 (0.28–1.14) | 0.111 | ||
Size ≥ 5cm | 1.9 (1.12 –3.24) | 0.018 | 2.13 (1.23–3.69) | 0.007 |
Multiple tumors | 1.44 (0.92–2.25) | 0.114 | ||
Vascular invasion | ||||
Macro-VI | 2.41 (1.52–3.84) | <0.001 | 2.08 (1.29–3.37) | 0.003 |
Micro-VI | 1.5 (0.97–2.34) | 0.071 | 1.61 (1.02–2.55) | 0.042 |
Poor differentiation | 1.15 (0.75–1.76) | 0.516 | ||
Child B | 1.1 (0.48–2.50) | 0.823 | ||
AFP ≥200 | 1.61 (1.04–2.49) | 0.032 | 1.42 (0.91–2.20) | 0.122 |
PD-L1 ≥3.0 | 1.66 (1.07–2.57) | 0.023 | 1.88 (1.18–2.99) | 0.008 |
PD-1 >1.0 | 1.31 (0.81–2.14) | 0.269 | ||
Liver cirrhosis | 1.28 (0.82–2.00) | 0.281 |
HRs, hazards ratios; CI, confidence intervals; AFP, alpha fetoprotein; PD-L1, programmed death-ligand 1; PD-1, programmed cell death protein 1.